Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.1564 USD | -1.88% | -6.57% | -27.66% |
Evolution of the average Target Price on Matinas BioPharma Holdings, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Matinas BioPharma Holdings, Inc.
Piper Sandler | |
HC Wainwright |
EPS Revisions
- Stock Market
- Equities
- MTNB Stock
- Consensus Matinas BioPharma Holdings, Inc.